In the US, Riastap (fibrinogen systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Congenital Fibrinogen Deficiency.
Ingredient matches for Riastap
Fibrinogen, Human is reported as an ingredient of Riastap in the following countries:
- United Kingdom
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.